{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:49:24Z","timestamp":1792298964490,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/1751-486x.12048","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T15:39:41Z","timestamp":1376926781000},"page":"294-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Review of Treatment and Management Modalities for Premenstrual Dysphoric Disorder"],"prefix":"10.1016","volume":"17","author":[{"given":"Kelli","family":"Kelderhouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Smith","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1751-486X.12048_bb0010","series-title":"ACOG practice bulletin: Premenstrual syndrome","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2000"},{"key":"10.1111\/1751-486X.12048_bb0015","series-title":"ACOG practice bulletin: Noncontraceptive uses of hormonal contraceptives","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2010"},{"key":"10.1111\/1751-486X.12048_bb0020","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association (APA)","year":"2000"},{"issue":"Suppl 1","key":"10.1111\/1751-486X.12048_bb0025","first-page":"S47","article-title":"Premenstrual syndrome: From etiology to treatment","volume":"55","author":"Andrzej","year":"2006","journal-title":"Maturitas"},{"issue":"11","key":"10.1111\/1751-486X.12048_bb0030","first-page":"129","article-title":"Treatment for PMDD? New OC regime eyed","volume":"29","author":"Anonymous","year":"2008","journal-title":"Contraceptive Technology Update"},{"issue":"8","key":"10.1111\/1751-486X.12048_bb0035","first-page":"918","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder","volume":"84","author":"Biggs","year":"2011","journal-title":"American Family Physician"},{"key":"10.1111\/1751-486X.12048_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpag.2006.10.007","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder","volume":"20","author":"Braverman","year":"2007","journal-title":"Journal of Pediatric Adolescent Gynecology"},{"key":"10.1111\/1751-486X.12048_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001396.pub2","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","volume":"2","author":"Brown","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1111\/1751-486X.12048_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10673220902891836","article-title":"Update on research and treatment of premenstrual dysphoric disorder","volume":"17","author":"Cunningham","year":"2009","journal-title":"Harvard Review of Psychiatry"},{"issue":"1","key":"10.1111\/1751-486X.12048_bb0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/0167482X.2010.538102","article-title":"Herbal treatments for alleviating premenstrual symptoms: A systematic review","volume":"32","author":"Dante","year":"2011","journal-title":"Journal of Psychosomatic Obstetrics and Gynecology"},{"issue":"4","key":"10.1111\/1751-486X.12048_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/01674820600747269","article-title":"Premenstrual dysphoric disorder: Prevalence, diagnostic considerations, and controversies","volume":"27","author":"Di Giulio","year":"2006","journal-title":"Journal of Psychosomatic Obstetrics and Gynecology"},{"issue":"5","key":"10.1111\/1751-486X.12048_bb0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/appi.ajp.2012.11081302","article-title":"Premenstrual dysphoric disorder: Evidence for a new category for DSM\u20105","volume":"169","author":"Epperson","year":"2012","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/1751-486X.12048_bb0070","article-title":"Progesterone for premenstrual syndrome","volume":"3","author":"Ford","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1111\/1751-486X.12048_bb0075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00737-010-0164-4","article-title":"Neuroticism\u2010related traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene\u2010linked polymorphism 5\u2010HTTPLPR","volume":"13","author":"Gingnell","year":"2010","journal-title":"Archives of Women's Mental Health"},{"issue":"7","key":"10.1111\/1751-486X.12048_bb0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1017\/S1092852900016849","article-title":"Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: Effective but not enough","volume":"13","author":"Halbreich","year":"2008","journal-title":"CNS Spectrums: The International Journal of Neuropsychiatric Medicine"},{"issue":"7","key":"10.1111\/1751-486X.12048_bb0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00023210-200620070-00001","article-title":"Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome\/premenstrual dysphoric disorder","volume":"20","author":"Halbreich","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1111\/1751-486X.12048_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.whi.2009.09.005","article-title":"Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity","volume":"20","author":"Heinemann","year":"2010","journal-title":"Women's Health Issues"},{"issue":"4","key":"10.1111\/1751-486X.12048_bb0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.AOG.0000140686.66212.1e","article-title":"Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: A clinical primer for practitioners","volume":"104","author":"Johnson","year":"2004","journal-title":"Obstetrics & Gynecology"},{"issue":"8","key":"10.1111\/1751-486X.12048_bb0100","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1471-0528.2011.02994.x","article-title":"Acupuncture for premenstrual syndrome: A systematic review and meta\u2010analysis of randomized controlled trials","volume":"118","author":"Kim","year":"2011","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"10.1111\/1751-486X.12048_bb0105","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"2","author":"Lopez","year":"2012","journal-title":"Cochrane Database of Systemtic Reviews"},{"issue":"2","key":"10.1111\/1751-486X.12048_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00737-009-0052-y","article-title":"Cognitive\u2010behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: A systematic review","volume":"12","author":"Lustyk","year":"2009","journal-title":"Archives of Women's Mental Health"},{"issue":"1","key":"10.1111\/1751-486X.12048_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.contraception.2010.10.010","article-title":"Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinyl estradiol 20 mcg plus drospirenone 3 mg administered in a 24\/4 regimen","volume":"84","author":"Marr","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"10.1111\/1751-486X.12048_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","article-title":"Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus","volume":"14","author":"O'Brien","year":"2011","journal-title":"Archives of Women's Mental Health"},{"issue":"4","key":"10.1111\/1751-486X.12048_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1139\/jpn.0828","article-title":"Premenstrual dysphoric disorder: Burden of illness and treatment update","volume":"33","author":"Pearlstein","year":"2007","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1111\/1751-486X.12048_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1874354400903010039","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder: Symptoms and cluster influences","volume":"3","author":"Perez\u2010Lopez","year":"2009","journal-title":"Open Psychiatry Journal"},{"issue":"3","key":"10.1111\/1751-486X.12048_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajog.2009.07.061","article-title":"Menstrual cycle\u2010related exacerbation of disease","volume":"202","author":"Pinkerton","year":"2010","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1111\/1751-486X.12048_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/da.21959","article-title":"Rapid response to fluoxetine in women with premenstrual dysphoric disorder","volume":"29","author":"Steinberg","year":"2012","journal-title":"Depression and Anxiety"},{"issue":"5","key":"10.1111\/1751-486X.12048_bb0145","first-page":"228","article-title":"Perimenstrual symptoms and syndromes: Guidelines for symptom management and self\u2010care","volume":"5","author":"Taylor","year":"2005","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1111\/1751-486X.12048_bb0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ogc.2009.10.010","article-title":"Understanding and treating premenstrual dysphoric disorder: An update for the women's health practitioner","volume":"36","author":"Vigod","year":"2009","journal-title":"Obstetrics & Gynecology Clinics of North America"},{"key":"10.1111\/1751-486X.12048_bb0155","series-title":"The ICD\u201010 Classification of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines","author":"World Health Organization (WHO)","year":"1992"},{"issue":"1","key":"10.1111\/1751-486X.12048_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jwh.2007.0417","article-title":"Burden of premenstrual dysphoric disorder on health\u2010related quality of life","volume":"17","author":"Yang","year":"2008","journal-title":"Journal of Women's Health"},{"issue":"2","key":"10.1111\/1751-486X.12048_bb0165","first-page":"101","article-title":"Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome","volume":"50","author":"Zamani","year":"2012","journal-title":"Acta Medica Iranica"},{"issue":"1","key":"10.1111\/1751-486X.12048_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4183\/aeb.2008.47","article-title":"Oral contraceptives with and without drospirenone in the treatment of premenstrual syndrome and premenstrual dysphoric disorder a multicentric study of 92 cases","volume":"4","author":"Zervoudis","year":"2008","journal-title":"Acta Endocrinologica (1841\u20100987)"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115307765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115307765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:40:35Z","timestamp":1761687635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485115307765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1751485115307765"],"URL":"https:\/\/doi.org\/10.1111\/1751-486x.12048","relation":{},"ISSN":["1751-4851"],"issn-type":[{"value":"1751-4851","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of Treatment and Management Modalities for Premenstrual Dysphoric Disorder","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1751-486X.12048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AWHONN. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}